Literature DB >> 6748839

Stridor and obstructive sleep apnea in Shy-Drager syndrome treated by laryngofissure and cord lateralization.

G S Kenyon, M C Apps, M Traub.   

Abstract

A patient with obstructive sleep apnea due to Shy-Drager syndrome, who has been successfully managed by cord lateralization, is presented. This has allowed successful rehabilitation of the patient without prejudicing subsequent surgery, and appears to be an effective procedure in this rare condition.

Entities:  

Mesh：

Year:  1984        PMID： 6748839     DOI： 10.1288/00005537-198408000-00022

Source DB:  PubMed          Journal:  Laryngoscope        ISSN： 0023-852X            Impact factor:   3.325


  6 in total

1.  Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy.

Authors:  E Isozaki; A Naito; S Horiguchi; R Kawamura; T Hayashida; H Tanabe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

2.  Effect of laser arytenoidectomy on respiratory stridor caused by multiple system atrophy.

Authors:  Shun-ichi Chitose; Atsushi Kikuchi; Keiko Ikezono; Hirohito Umeno; Tadashi Nakashima
Journal:  J Clin Sleep Med       Date:  2012-12-15       Impact factor: 4.062

3.  The posterior crico-arytenoid muscle in two cases of Shy-Drager syndrome with laryngeal stridor. Comparison of the histological, histochemical and biometric findings.

Authors:  J DeReuck; W Van Landegem
Journal:  J Neurol       Date:  1987-04       Impact factor: 4.849

Review 4.  Movement disorder emergencies.

Authors:  Steven J Frucht
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 5.  Movement disorder emergencies.

Authors:  Kathleen L Poston; Steven J Frucht
Journal:  J Neurol       Date:  2008-08       Impact factor: 4.849

6.  Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?

Authors:  Florin Gandor; Annemarie Vogel; Inga Claus; Sigrid Ahring; Doreen Gruber; Hans-Jochen Heinze; Rainer Dziewas; Georg Ebersbach; Tobias Warnecke
Journal:  Mov Disord       Date:  2020-08-05       Impact factor: 10.338
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.